Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The primary objective of this study is to evaluate the abuse potential of intranasal esketamine (112 milligram and 84 mg) compared to racemic intravenous ketamine (0.5 mg/kg) in nondependent, recreational polydrug users of perception-altering drugs.
Epistemonikos ID: 1e4c72a7e8c42d14df8a6b2dc817266943aa37ce
First added on: May 12, 2024